“…It has in-vitro and in-vivo antiviral activity, interfering with DNA and RNA replication of a wide range of viruses, including herpes, influenza A and B, hepatitis B, coronavirus, and SARS (Pompei, et al, 1979;Hirabayashi et al, 1991;Badam, 1994;Lin, 2003;Hoever, et al 2005;Lee, et al, 2007). This pharmaceutical preparation has also been demonstrated to be able to prevent the virion from hatching from its capsid (Pompei, et al, 1979;Lin, 2003), apparently due to a dose-dependent inhibition of kinase-P phosphorylation (Chavali, et al, 1987;Ohtsuki and Ishida, 1988).…”